Loading
Life sciences · Journal article
Health Science Reports · September 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
ABSTRACT Background and Aims Diabetes mellitus contributes significantly to the global disease burden, affecting approximately 537 million adults worldwide, with over 75% residing in low and middle‐income countries (LMICs). In Zambia, evidence on metabolic predictors of vascular complications among patients with Type 2 Diabetes Mellitus (T2DM) is limited. This study aimed to estimate the incidence of vascular complications and identify metabolic and clinical factors associated with their occurrence among newly diagnosed T2DM patients. Methods A retrospective cohort study was conducted among 315 adults aged ≥ 18 years, randomly selected from the University Teaching Hospital Diabetes Clinic registry in Zambia. Participants diagnosed between January 2013 and December 2016 were followed up until December 2023. Cox proportional hazards regression models estimated hazard ratios (HRs) at 95% confidence intervals, with best‐fitting model identified using Akaike Information Criterion. Statistical significance was set at p < 0.05. Results Of 315 participants, 52.1% were female, with a mean age of 49.6 ± 13.5 years. Increasing age (HR = 1.047, 95% CI: 1.02–1.07, p = 0.001), hypertension (HR = 2.196, 95% CI: 1.58–3.03, p < 0.001), elevated cholesterol (HR = 1.533, 95% CI: 1.00–2.33, p = 0.048), and poor glycaemic control (HR = 10.047, 95% CI: 2.04–49.31, p = 0.004) were predictors. Overweight and obesity increased risk (HR = 2.035, 95% CI: 1.24–3.33, p = 0.005; HR = 1.812, 95% CI: 1.13–2.90, p = 0.005). Age‐glycated hemoglobin interaction (HR = 1.006, 95% CI: 0.934–0.989, p = 0.007) indicated amplified poor glycaemic control effect with advancing age. Conclusion Advancing age, hypertension, dyslipidaemia, obesity, and poor glycaemic control were key predictors. Age‐HbA1c interaction underscores need for age‐sensitive management. Integrating metabolic risk prediction could enhance early detection, risk stratification, and prevention, reducing diabetes burden in Zambia and LMICs.